@article {1970,
	title = {Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.},
	journal = {The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions},
	volume = {19},
	year = {2010},
	month = {2010 Jan-Feb},
	pages = {4-16},
	abstract = {Drug interactions are a leading cause of morbidity and mortality. Methadone and buprenorphine are frequently prescribed for the treatment of opioid addiction. Patients needing treatment with these medications often have co-occurring medical and mental illnesses that require medication treatment. The abuse of illicit substances is also common in opioid-addicted individuals. These clinical realities place patients being treated with methadone and buprenorphine at risk for potentially toxic drug interactions. A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans. This review summarizes current literature in this area.},
	keywords = {Buprenorphine, Cytochrome P-450 CYP2D6, Drug Interactions, Humans, Methadone, Opioid-Related Disorders, Prescription Drugs, Street Drugs, Substance-Related Disorders},
	issn = {1521-0391},
	doi = {10.1111/j.1530-0277.2011.01601.x},
	author = {McCance-Katz, Elinore F and Sullivan, Lynn E and Nallani, Srikanth}
}
